Structural polymorphanisms in class I and II HLA molecules are the greatest immunological barrier to clinical transplantation in humans. For transplantation of bone marrow and solid organs, survival of graft and patient survival are improved with good HLA matching. During the last 15 years evidence has accumulated that traditional serological typing does not, and probably cannot, distinguish all the different HLA molecules. Moreover, the serologically undetected differences are often those stimulating strong alloreactive T cell responses which are likely to contribute to transplant rejection. Other disadvantages of serological HLA typing are the complexity, low titer, and limited supply of the typing alloantisera. These and other factors have resulted in relatively poor definition of the HLA molecules of American Blacks, Native Americans, and other minority ethnic populations in the United states. This decreases the probability of finding a good match between transplant donors and recipients in those populations. For these reasons, new HLA typing methods based on the nucleotide sequences encoding the polymorphic polypeptides of the class I and II molecules. The proposed research aims first to provide the essential nucleotide sequence information from class I HLA alleles that is a prerequisite for design of DNA-based typing, and second to develop strategies for typing based on polymerase chain on polymerase chain amplification of DNA and oligonucleotide hybridization. This investigation will build on extensive experience in the study of Class I HLA molecules. Alleles of the HLA-A and B loci will be isolated and sequenced with emphasis on those found at high frequency in American Blacks and Amerindians. Application of automated DNA sequencing to speed the acquisition of this data will be made. A complicating factor in the development of DNA-based typing for class I HLA molecules is the presence in the human genome of 15 genes, pseudogenes and gene fragments that cross- hybridize with HLA-A, B, and C. The structure and polymorphism of those additional genes will be characterized and this information will reveal potential problems and permit their avoidance. The accumulated sequence information will be used to develop """"""""typing"""""""" strategies that discriminate HLA-A, B, C alleles on the basis of hybridization of sequence specific oligonucleotides to segments of genomic DNA amplified by the polymerase chain reaction. The alleles of each locus will be divided into groups and in the initial stages typing within a group will be developed. Initial groups for study are the HLA-A2/A28 family and the HLA-B17/B5/B35 family. Once accurate, discriminating typing for these groups has been established then further groups will be selected for study. In addition to laying a foundation for accurate, routine, and comprehensive class I HLA typing for transplantation this project will develop information and reagents invaluable to future research on T-cell responses in human diseases.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL047153-02
Application #
3366378
Study Section
Special Emphasis Panel (SRC (MR))
Project Start
1991-08-01
Project End
1995-05-31
Budget Start
1992-06-01
Budget End
1993-05-31
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Kubens, B S; Arnett, K L; Adams, E J et al. (1995) Definition of a new HLA-B7 subtype (B*0704) by isoelectric focusing, family studies and DNA sequence analysis. Tissue Antigens 45:322-7
Moses, J H; Marsh, S G; Arnett, K L et al. (1995) On the nucleotide sequences of B*2702 and B*2705. Tissue Antigens 46:50-3
Domena, J D; Little, A M; Arnett, K L et al. (1994) A small test of a sequence-based typing method: definition of the B*1520 allele. Tissue Antigens 44:217-24
Hildebrand, W H; Domena, J D; Shen, S Y et al. (1994) The HLA-B7Qui antigen is encoded by a new subtype of HLA-B27 (B*2708). Tissue Antigens 44:47-51
Hildebrand, W H; Domena, J D; Shen, S Y et al. (1994) HLA-B15: a widespread and diverse family of HLA-B alleles. Tissue Antigens 43:209-18
Domena, J D; Arnett, K L; Marsh, S G et al. (1994) Alloantibodies can discriminate three populations of HLA-B40 molecules encoded by B*4002. Tissue Antigens 44:57-8
Little, A M; Domena, J D; Hildebrand, W H et al. (1994) HLA-B67: a member of the HLA-B16 family that expresses the ME1 epitope. Tissue Antigens 43:38-43
Parham, P; Arnett, K L; Adams, E J et al. (1994) The HLA-B73 antigen has a most unusual structure that defines a second lineage of HLA-B alleles. Tissue Antigens 43:302-13
Hildebrand, W H; Domena, J D; Parham, P (1993) Primary structure shows HLA-B59 to be a hybrid of HLA-B55 and HLA-B51, and not a subtype of HLA-B8. Tissue Antigens 41:190-5
Domena, J D; Azumi, K; Bias, W B et al. (1993) B*1401 encodes the B64 antigen: the B64 and B65 splits of B14 differ only at residue 11, a buried amino acid. Tissue Antigens 41:110-1

Showing the most recent 10 out of 17 publications